The author discusses the condition of clinical neuroscience and brain diseases as of 2012. He says that the treatment progress for Alzheimer's disease (AD) has not been made and some theories are still modified. He mentions that Michael J. Fox Foundation invests in studies aimed at finding biomarkers for Parkinson's disease treatment.